Related by context. All words. (Click for frequent words.) 66 neuropsychiatric diseases 66 vascular abnormalities 65 thyroid dysfunction 65 G6PD deficiency 65 comorbid depression 64 neuro degenerative disorders 64 arterial calcification 64 pharmacological therapies 64 neovascularisation 64 myocardial dysfunction 64 mitochondrial toxicity 64 motor neuron degeneration 64 etiologic factors 63 hormonal abnormalities 63 renal fibrosis 63 antiplatelet therapies 63 physiologic mechanisms 63 atherogenesis 63 atherothrombotic 63 torsade de pointes 63 Genetic predisposition 63 Magnesium deficiency 63 poststroke depression 63 thromboembolic disease 63 neurosensory 63 epilepsies 63 thiopurine 63 hepatic cirrhosis 63 comorbid disorders 62 neuropsychological impairments 62 vascular dysfunction 62 colorectal carcinogenesis 62 neurocognitive deficits 62 urolithiasis 62 biphosphonates 62 primary hyperparathyroidism 62 optic neuropathy NAION 62 biochemical abnormalities 62 pathophysiological mechanisms 62 metabolic dysfunction 62 pathogenic mechanisms 62 Alzheimer Disease AD 62 venous thromboembolic disease 62 malignant lymphomas 62 pathophysiologic 62 Mood disorders 62 metabolic abnormality 61 Chronic inflammation 61 Dental caries 61 renal scarring 61 repolarization 61 neurobiological underpinnings 61 biochemical imbalances 61 monogenic 61 neoplastic diseases 61 Comorbid 61 Genetic variants 61 hyperhomocysteinemia 61 receptor ligands 61 cerebrovascular diseases 61 intracerebral haemorrhage 61 pain syndromes 61 rheumatic disorders 61 dentinal hypersensitivity 61 gastrointestinal dysfunction 61 aldosterone hormone 61 hyperprolactinemia 61 cardiovascular disease hypertension 61 neuroinflammation 61 Aortic stenosis 61 cystic fibrosis chronic pancreatitis 61 vertebral subluxation 61 bicuspid aortic valves 61 dysrhythmias 61 cardiometabolic disorders 61 somatoform disorders 61 Cognitive impairment 61 skeletal metastases 61 neuronal dysfunction 61 Glucocorticoids 61 immunodeficiencies 61 post surgical adhesions 61 Ischemic 61 intestinal motility 61 macrovascular events 61 pressure natriuresis 61 LVNC 60 SSc 60 atrial tachyarrhythmias 60 neuropsychiatric disorder 60 neuroinflammatory 60 idiopathic pulmonary 60 Wernicke Korsakoff syndrome 60 comorbid psychiatric 60 platelet activation 60 antiphospholipid syndrome 60 psychopharmacologic 60 vasodilatation 60 aetiological 60 predisposing factor 60 chronic periodontitis 60 aetiology 60 degenerative neurological diseases 60 molecular determinants 60 multifactorial disease 60 pathophysiological 60 neurosteroid 60 myopathies 60 protein misfolding diseases 60 mitochondrial decay 60 dissolving blood clots 60 Pseudomonas aeruginosa infections 60 IntroductionThe 60 decubitus ulcers 60 pathological fractures 60 metabolic disturbances 60 endogenous opioid 60 serous ovarian cancer 60 myocardial fibrosis 60 gastric carcinoma 60 antioxidant supplementation 60 neuro psychiatric disorders 60 pulmonary hypertension PH 60 cerebral vasospasm 60 molecular biomarkers 60 atherothrombotic disease 60 extracellular dopamine 60 hereditary predisposition 60 comorbid anxiety 60 cardiac repolarization 60 antitumor efficacy 60 CP CPPS 60 photodamaged skin 60 etiologic 60 cardiac conduction 60 autonomic dysfunction 60 etiological 60 subclinical atherosclerosis 60 Prostatitis 60 hippocampal atrophy 60 morbidities 60 non pharmacological interventions 60 atrial arrhythmias 60 Vitamin D insufficiency 60 cardioprotection 60 prenatal exposures 60 cardiac fibrosis 60 differential gene expression 60 lipid parameters 60 thrombophilia 60 hypercoagulable 59 hormone aldosterone 59 metabolic abnormalities 59 postoperative atrial fibrillation 59 neuro developmental disorders 59 maladaptive behaviors 59 psychosocial variables 59 recurrent miscarriage 59 induced cardiomyopathy 59 intracranial stenosis 59 biologic pathway 59 hematologic parameters 59 phenotypic expression 59 metabolic derangement 59 penile erection 59 granulomatous 59 depression suicidal ideation 59 pathophysiologic mechanisms 59 myocardial ischaemia 59 Neurodegenerative diseases 59 tumor hypoxia 59 pharmacological interventions 59 imatinib resistance 59 genital herpes infections 59 underdiagnosis 59 neurocognitive impairment 59 neuropsychological deficits 59 T1DM 59 thrombotic complications 59 somatostatin analogs 59 androgen deficiency 59 underlying pathophysiology 59 postoperative AF 59 IgG4 59 myeloproliferative diseases 59 airway hyperresponsiveness 59 kidney urologic 59 impaired cognition 59 cortical excitability 59 muscular dystrophies 59 OSAHS 59 neurovascular diseases 59 ANCA associated 59 Adverse effects 59 carcinomatosis 59 bone metabolism 59 Atopic dermatitis 59 lupus scleroderma 59 respiratory gastrointestinal 59 hypothalamic pituitary adrenal axis 59 antimetabolites 59 cardiac valvulopathy 59 hypocalcaemia 59 electrophysiologic 59 Oral mucositis 59 microangiopathy 59 MTHFD1L gene 59 comorbid psychiatric disorders 59 nociceptive pain 59 arterial inflammation 59 stratifying patients 59 nonalcoholic steatohepatitis 59 Thyroid disorders 59 Heavy menstrual bleeding 59 pharmacologic treatments 59 immunopathology 59 Neurological disorders 59 secondary hyperparathyroidism 59 CB2 receptor 59 bullous 59 ERK signaling 59 degenerative disorders 59 Genetic variation 59 CYP #A# 59 symptomology 59 chromosome aberrations 59 thyrotropin 59 Hypotension 59 xenobiotic 59 somatic symptoms 59 obstructive sleep 59 cardiac biomarkers 59 anticholinergic agents 59 candidemia 59 systemic fungal infections 59 familial clustering 59 mitochondrial enzyme 59 microbial biofilms 59 respiratory viral infections 59 channelopathies 59 Vitamin B# deficiency 59 inhaled anesthetics 58 hepatic steatosis 58 intravascular hemolysis 58 pharmacologic approaches 58 immunoregulation 58 inhaled bronchodilators 58 hemoglobinopathies 58 arterial stiffening 58 pharmacological approaches 58 psychiatric comorbidity 58 causal pathway 58 cerebellar vermis 58 nongenetic 58 anticonvulsant medications 58 Atypical antipsychotics 58 leiomyomas 58 colorectal adenoma 58 myelofibrosis polycythemia vera 58 Chronic insomnia 58 ADAMTS# 58 Zinc deficiency 58 malignant neoplasms 58 Venous thromboembolism 58 GI motility disorders 58 recurrent venous thromboembolism 58 squamous cell lung cancer 58 acamprosate calcium 58 syndrome OSAS 58 treating neuropathic pain 58 leukotriene pathway 58 cardiac troponin 58 antibody mediated 58 cardiomyopathies 58 immuno modulatory 58 serum lipid 58 diabetic microvascular complications 58 carotid atherosclerosis 58 melanin synthesis 58 proteoglycan 58 thyroid deficiency 58 thrombo embolic 58 reproductive tract infections 58 neural degeneration 58 treatmentof 58 metaplasia 58 Alzheimer pathology 58 socioeconomic inequalities 58 extramedullary 58 chronic thromboembolic pulmonary 58 epigenetic alterations 58 pharmacological treatments 58 dopamine D2 receptors 58 antiplatelet medications 58 reproductive endocrine 58 cytopenias 58 blood clotting disorders 58 PTH secretion 58 neuropsychiatric symptoms 58 overactive bladder symptoms 58 nephrotoxicity 58 NMDA antagonists 58 pharmacodynamic parameters 58 ischemia induced 58 atherosclerotic coronary 58 Sarcopenia 58 immunodeficiency disorders 58 gait disturbance 58 serum parathyroid hormone 58 NAGS deficiency 58 Treg cell 58 neurobiological mechanisms 58 chronic myocardial ischemia 58 DACH platinum 58 Overactive bladder 58 Excessive daytime sleepiness 58 affective psychoses 58 Mucositis 58 potentially modifiable 58 artery stenosis 58 lethal arrhythmias 58 teratogenicity 58 inflammatory biomarkers 58 dietary antioxidants 58 adrenal suppression 58 psychiatric comorbidities 58 abdominal adiposity 58 opiate dependence 58 fibrin deposition 58 intimal hyperplasia 58 γ secretase 58 mycosis 58 SIADH 58 ciliopathies 58 radiographic findings 58 coronary microvascular 58 cardio vascular disease 58 deferiprone 58 metabonomics 58 nonbacterial prostatitis 58 airway responsiveness 58 neuritic plaques 58 cartilage degeneration 58 nonhealing wounds 58 lipid elevations 58 lung fibrosis 58 glial tumors 58 antiangiogenic agents 58 Takayasu arteritis 58 signaling cascades 58 vaso occlusive crisis 58 sJIA 58 leptin deficiency 58 periodontal tissues 58 prognostic indicators 58 acute ischemia 58 ischemic mitral regurgitation 58 functional gastrointestinal disorders 58 Squalamine 58 mGluR2 NAM 58 hyperammonemia 58 hydrops 58 Cognitive therapy 58 rheumatic diseases 58 epigenetic markers 58 primary spontaneous pneumothorax 58 Iron deficiency anemia 58 circulating estrogens 58 insulin resistance syndrome 58 nerve degeneration 58 noncardiac 58 neurologic disorders 58 cholinergic tone 58 systemic amyloidosis 58 Periodontitis 58 EBV infection 58 Torsades de Pointes 58 APOE genotype 58 atrial fibrillation AFib 58 hormonal deficiencies 58 albumin excretion 58 diabetic polyneuropathy 58 cortisol secretion 58 ALI ARDS 58 Sleep disordered breathing 58 intracranial hemorrhage ICH 58 developmental neurotoxicity 58 overactivation 58 pharmacological therapy 58 immunosuppressive regimens 58 neuropathological 58 symptomatic VTE 57 myocardial reperfusion 57 valvular heart disease 57 generalized seizures 57 HIV HCV coinfected 57 androgen excess 57 antithrombotic therapy 57 hyperacute 57 chronic LBP 57 neurologic sequelae 57 abnormal lipids 57 probiotic supplementation 57 CKD MBD 57 hepatotoxic 57 perfusion MRI 57 clonal expansion 57 biopsychosocial 57 immune reconstitution syndrome 57 cardiovascular cerebrovascular 57 proliferative disorders 57 infective endocarditis 57 daytime drowsiness 57 metabolic acidosis 57 tissue fibrosis 57 thetreatment 57 dentin hypersensitivity 57 atherosclerotic disease 57 hepatic encephalopathy HE 57 psychosocial functioning 57 causal pathways 57 Erythropoietic therapies may 57 coagulopathy 57 pulmonary dysfunction 57 serum bicarbonate 57 allograft rejection 57 gastric cardia 57 hematologic disorders 57 lipoprotein metabolism 57 neurologic symptoms 57 ligand induced 57 Chlamydia trachomatis infection 57 gastro esophageal reflux 57 citicoline 57 bacterial prostatitis 57 neuro protective 57 intranasal corticosteroids 57 Urinary tract 57 serum biomarkers 57 disc degeneration 57 neurologic diseases 57 IL 1ß 57 allergic dermatitis 57 pharmacologic interventions 57 familial hypercholesterolemia FH 57 tardive dyskinesia TD 57 endothelial activation 57 cardiac abnormalities 57 CVD cardiovascular disease 57 HbF 57 platelet deficiency 57 pyoderma 57 fibrosis progression 57 histone methylation 57 statins cholesterol lowering 57 serum homocysteine 57 hyperalgesia 57 extrapyramidal 57 ovarian hormones 57 neurological degeneration 57 diabetic retinopathy DR 57 Cardiac hypertrophy 57 HER2 overexpression 57 cytopenia 57 prostate cancer CaP 57 hippocampal sclerosis 57 dysglycemia 57 Keratitis 57 diabetic kidney 57 serum BDNF 57 premenstrual syndrome PMS 57 atopic disorders 57 AA Amyloidosis 57 coagulation abnormalities 57 therapeutic regimens 57 adrenal hormone 57 benign prostatic hypertrophy BPH 57 intracranial hypertension 57 CETP gene 57 Bisphosphonate 57 Socioeconomic status 57 untreated celiac disease 57 Left ventricular hypertrophy 57 electrolyte disturbances 57 neurodevelopmental disorders 57 anti androgens 57 intestinal microflora 57 Parkinson disease Alzheimer disease 57 arterial hypertension 57 inflammatory bowel syndrome 57 brain lesions 57 morphological abnormalities 57 myofascial pain syndrome 57 chronic venous insufficiency 57 idiopathic intracranial hypertension 57 dyslipidaemia 57 atypical antipsychotic medications 57 etiologies 57 baroreflex 57 Bruxism 57 euthymic patients 57 nonmelanoma skin cancers 57 neurobehavioral disorder 57 atherogenic dyslipidemia 57 microvascular dysfunction 57 genetic susceptibilities 57 carotid plaques 57 behavioral disinhibition 57 STAT3 signaling 57 childhood acute lymphoblastic 57 intestinal permeability 57 pharmacologic intervention 57 depressive illnesses 57 Melasma 57 hypercholesterolaemia 57 Oxidative damage 57 mtDNA mutations 57 haematological toxicity 57 hemodilution 57 erythema nodosum 57 androgen depletion therapy 57 rhythm disturbances 57 Critical limb ischemia 57 pharmacotherapies 57 Candida infection 57 Cardiotoxicity 57 molecular mechanisms underlying 57 de novo mutations 57 vestibular dysfunction 57 autoinflammatory diseases 57 oral malodor 57 haematologic 57 immunological mechanisms 57 syndromic 57 hypercalciuria 57 platelet clumping 57 HIV lipodystrophy 57 hypothalamic pituitary 57 sonographic diagnosis 57 molecularly targeted therapies 57 atopic disease 57 testicular tumors 57 postmenopausal hormone 57 efficacious treatments 57 dysfunctional voiding 57 IDDM 57 intra abdominal abscess 57 serum urate levels 57 CVD mortality 57 BCL#A 57 telogen effluvium 57 prostaglandin analogues 57 Eisenmenger syndrome 57 neovascular 57 connective tissue diseases 57 neuropathologic 57 medication nonadherence 57 Surgical excision 57 antidepressive 57 maturational 57 paraneoplastic 57 Genetic variations 57 Xerostomia 57 NFkappaB 57 neuropsychological functioning 57 Exacerbation 57 fibrotic disease 57 variant angina 57 thrombo embolism 57 alpha#beta# 57 sonographic appearance 57 genetic polymorphisms 57 immunomodulation 57 psychostimulant 57 p# activation 57 pulmonary toxicity 57 osteoblastic 57 hepatocellular 57 anemias 57 rheumatic disease 57 hypoperfusion 57 irregular heartbeat atrial fibrillation 57 Pulmonary hypertension 57 dietary interventions 57 rheumatoid arthritis osteoarthritis ankylosing 57 photoaging 57 elevated IOP 57 hyperparathyroidism 57 angiographically 57 invasive candidiasis 57 acute myocardial ischemia 57 Parkinsonian symptoms 57 Tß4 57 bony metastases 57 seminomas 57 neuro degeneration 57 neurodevelopmental disorder 57 gynecological malignancies 57 Skeletal muscle 57 reperfusion injury 57 metabolic dysfunctions 56 Barrett esophagus precancerous 56 neurological manifestations 56 epithelial tumors 56 neuro degenerative diseases 56 Diabetic neuropathy 56 AChE inhibitors 56 heart arrhythmias 56 psychotherapies 56 EphB2 levels 56 underlying molecular mechanisms 56 histologic subtype 56 intercellular signaling 56 Periodontal disease 56 dominantly inherited 56 HeFH 56 dyslipidemias 56 hypericin 56 intensive statin therapy 56 PHPT 56 posttranslational modification 56 Barrett esophagus BE 56 proinflammatory cytokine 56 neuronal degeneration 56 stochastic resonance 56 biochemical mechanisms 56 hypertrophic scars 56 allogeneic HSCT 56 growth hormone secretion 56 neuro developmental 56 threatening ventricular arrhythmias 56 BMPR2 56 mGluR5 antagonist 56 opioid antagonists 56 nephrogenic fibrosing dermopathy 56 tic severity 56 bronchopulmonary dysplasia BPD 56 Alpha lipoic acid 56 chronic relapsing 56 antithrombotic agents 56 thyrotropin levels 56 Pathological gambling 56 tooth decay gum 56 Candida overgrowth 56 dermopathy 56 neuropsychiatric disorders 56 pharmacological intervention 56 epilepsy Parkinson disease 56 neurocognitive disorder 56 mal absorption 56 remyelination 56 pleiotropic effects 56 Alzheimer disease cognitive impairment 56 Sjögren syndrome 56 diagnostic biomarker 56 obstructive coronary 56 Testosterone deficiency 56 Chronic pelvic 56 prostate carcinogenesis 56 thrombolytic agents 56 familial adenomatous polyposis 56 hippocampal neurogenesis 56 induce orthostatic hypotension 56 neonatal respiratory distress 56 neurological abnormalities 56 subclinical disease 56 arterial thrombosis 56 hematological toxicity 56 excitotoxic 56 Androgen deprivation therapy 56 serum PTH 56 prefrontal cortical 56 lupus multiple sclerosis 56 minimally invasive therapies 56 molecular abnormalities 56 ergot alkaloids 56 engineered RAP peptides 56 antiemetics 56 ionotropic 56 hormones secreted 56 varenicline Chantix 56 diaper dermatitis 56 glucocorticoid receptors 56 neuronal signaling 56 therapeutic modalities 56 juvenile idiopathic arthritis 56 myeloperoxidase 56 choroidal neovascularization 56 chronic hepatitis cirrhosis 56 gastric distention 56 autoantibody levels 56 affective disorders 56 aerodigestive tract 56 tumor necrosis 56 Aviptadil 56 riociguat 56 retinal vascular 56 mitral stenosis 56 gastrointestinal absorption 56 Hypertrophic 56 erythropoietic 56 systemic inflammation 56 esophageal reflux 56 Nonspecific 56 hypercalcaemia 56 validating biomarkers 56 pemphigus vulgaris 56 acne vulgaris 56 systolic hypertension 56 periodontal infections 56 hyoscyamine 56 neurocognition 56 neurotrophic 56 da mage 56 neuron degeneration 56 Catheter Associated 56 authors hypothesize 56 preserved ejection fraction 56 enzyme cofactor 56 neuronal nicotinic receptors NNRs 56 Singh Manoux 56 myeloproliferative disorders 56 hormone imbalances 56 chromosomal rearrangement 56 symptomatic intracranial hemorrhage 56 fulminant hepatic failure 56 Endometrial cancer 56 LHRH antagonists 56 genetic syndromes 56 antidepressant efficacy 56 atherosclerotic vascular disease 56 overt nephropathy 56 acne rosacea 56 ocular disorders 56 Calcium intake 56 TMJD 56 diathesis 56 induced hepatotoxicity 56 Endothelial dysfunction 56 macrolide resistance 56 renal biopsy 56 hepatorenal syndrome 56 Chronic Prostatitis 56 Cognitive behavioral 56 carbohydrate metabolism 56 pathogenetic mechanisms 56 Cognitive dysfunction 56 multi factorial disease 56 Estrogen deficiency 56 Nephrogenic Systemic Fibrosis NSF 56 postoperative delirium 56 treat brain aneurysms 56 biologic pathways 56 abnormal lipid 56 coagulation cascade 56 HPA axis 56 Nicotine dependence 56 obesity insulin resistance 56 chlamydial 56 persistent pulmonary hypertension 56 parietal cortices 56 viral etiology 56 mechanistic studies 56 cholestasis 56 prolonged QT interval 56 rebleeding 56 investigational therapies 56 vascular reactivity 56 cAMP signaling 56 geriatric syndromes 56 dopaminergic therapy 56 Fc receptor 56 nosology 56 rheumatologic 56 autosomal dominant inheritance 56 environmental toxicants 56 intracellular signal transduction 56 bronchial hyperresponsiveness 56 lysosomal storage diseases 56 microvascular disease 56 autoimmune thyroiditis 56 AST ALT 56 cardiac contractility 56 asplenia 56 macrovascular complications 56 erythropoiesis 56 paroxysmal nocturnal hemoglobinuria 56 polymicrobial infections 56 fungus Cryptococcus neoformans 56 topical calcineurin inhibitors 56 postural stability 56 excitotoxicity 56 antimicrobial prophylaxis 56 genetic determinants 56 JAK2 enzyme 56 synaptic function 56 aromatase inhibitors AIs 56 carotid IMT 56 Zollinger Ellison Syndrome 56 dermatologic conditions 56 orofacial pain 56 muscarinic receptors 56 Juvenile Idiopathic Arthritis 56 ventricular remodeling 56 neovascular diseases 56 sequela 56 hyper IgE syndrome 56 β blockers 56 urate levels 56 AT1R 56 functional mitral regurgitation 56 apneic episodes 56 Diabetes mellitus 56 gastrointestinal GI bleeding 56 malarial infections 56 bacteriuria 56 cardiotoxic 56 TTR amyloidosis 56 Valdoxan 56 Leukemias 56 cardioembolic stroke 56 beta1 integrin 56 nasal polyposis 56 multisystemic 56 alexithymia 56 Autoimmune diseases 56 abnormal genital 56 levodopa induced 56 interventional therapies 56 atheromatous 56 behavioral disturbances 56 vasodilators 56 QTc intervals 56 hypovitaminosis D 56 foveal thickness 56 proton MR spectroscopy 56 chronic rhinosinusitis CRS 56 Pulmonary Embolism PE 56 mania hypomania 56 nonalcoholic steatohepatitis NASH 56 allergic inflammation 56 GLP 1R 56 folic acid deficiency 56 neurobehavioral disorders 56 Renal dysfunction 56 Parkinson Disease PD 56 Chronic sinusitis 56 IPAH 56 lipodystrophy syndrome 56 parkinsonian 56 amyloid deposition 56 serum calcium 56 Premenstrual Dysphoric Disorder 56 Rh incompatibility 56 biomarker assay 56 intestinal mucosal 56 Heritability 56 DNA demethylation 56 hematological disorders 56 epigenetic changes 56 Pemphigus 56 PARP inhibition 56 bile acid synthesis 56 serologic tests 56 tumoral 56 endocrine dysfunction 56 natriuretic peptides 56 distal embolization 56 leaky gut 56 Haptoglobin 56 choroidal vasculopathy 56 fast skeletal troponin 56 gastroesophageal 56 TGF beta signaling 56 adrenal hormones 56 latent tuberculosis TB 56 cardio metabolic diseases 56 Alternative splicing 56 tonic clonic seizures 55 shorter telomere length 55 neurogenerative diseases 55 predisposing factors 55 nociception 55 blood coagulation disorders 55 cardiac malformations 55 colorectal cancer CRC 55 Retinopathy 55 airway constriction 55 electroencephalographic 55 hypovolemia 55 coronary artery atherosclerosis 55 neuritic 55 ziconotide 55 airway remodeling 55 gastric adenocarcinoma 55 parkinsonian symptoms 55 nonpharmacologic 55 hypometabolism 55 PCNSL 55 herpes zoster shingles 55 SRBD 55 cardiac allograft vasculopathy 55 TMS Therapy 55 immune modulating 55 Leydig cell 55 Non Alcoholic Fatty 55 telomere shortening 55 impaired glucose metabolism 55 diagnosing ADHD 55 colon carcinogenesis 55 hormone therapy HT 55 cranial irradiation 55 GABA aminotransferase 55 swallowing disorders 55 proliferative diabetic retinopathy 55 Herniated discs 55 PDE# inhibitors 55 sociodemographic factors 55 vesicoureteral reflux 55 agomelatine 55 antiepileptics 55 indwelling catheters 55 psychomotor retardation 55 cognitive dysfunctions 55 demethylation 55 clinicopathological 55 biopsychosocial model 55 gastric carcinogenesis 55 tiagabine 55 antithrombotics 55 multiorgan 55 Acne Rosacea 55 de ath 55 arterial thickening 55 murine model 55 pemphigus 55 metabolic syndromes 55 fluoroquinolone resistance 55 serum phosphate 55 enzymatic degradation 55 primary dysmenorrhoea 55 constipation OIC 55 hepatic toxicity 55 diagnostic modality 55 NSAID induced 55 perfusion abnormalities 55 Psoriatic arthritis 55 Tasimelteon 55 Radiofrequency ablation 55 Systemic lupus erythematosus SLE 55 atherothrombosis 55 autism spectrum disorders ASD 55 atrophic gastritis 55 mixed hyperlipidemia 55 emphysema COPD 55 emotional dysregulation 55 osteoarthritis rheumatoid arthritis 55 mitochondrial metabolism 55 synovial cells 55 breast abscesses 55 cataract formation 55 hypercoagulability 55 Legg Calvé Perthes disease 55 hypervascular tumors 55 malabsorptive 55 mediated inhibition 55 ventricular tachyarrhythmia 55 Mitochondrial dysfunction 55 osteoporotic vertebral fractures 55 nonproliferative 55 neurodevelopmental outcome 55 Huntingtons disease 55 neurodevelopmental outcomes 55 resynchronization therapy 55 neurocognitive function 55 symptomatic intracranial 55 gene rearrangements 55 esophagogastric 55 cognitive affective 55 trastuzumab Herceptin ® 55 breast endometrial 55 Bacterial infection 55 Psychosocial interventions 55 prognostic markers 55 Acamprosate 55 FGFs 55 psychiatric morbidity 55 anticholinergic effects 55 monoamine 55 thyroid carcinoma 55 Bucindolol 55 KCNH2 55 clefting 55 endophenotypes 55 cardiometabolic diseases 55 RIP1 55 chlamydial infection 55 candida infections 55 teratogens